Aptamer-based Targeting

Aptamer-Based Targeting is a molecular targeting strategy that utilizes single-stranded DNA or RNA oligonucleotides selected for high-affinity and specific binding to target biomolecules, enabling precise delivery of therapeutic or diagnostic agents in active targeting applications.

507

Publications

31.4K

Citations

2.9K

Authors

935

Institutions

Publications per year

2017–2026

273

Authors

2.9K

  1. WT
    Weihong Tan

    Hunan University, China

    45 publications · 2.9K citations

    29

    h-index

  2. KA
    Khalil Abnous

    Mashhad University of Medical Sciences, Iran

    21 publications · 1.6K citations

    20

    h-index

  3. MR
    Mohammad Ramezani

    Mashhad University of Medical Sciences, Iran

    17 publications · 1.4K citations

    17

    h-index

  4. BA
    Bruce A. Sullenger

    Duke Medical Center, United States

    15 publications · 1.9K citations

    15

    h-index

  5. SM
    Seyed Mohammad Taghdisi

    Mashhad University of Medical Sciences, Iran

    14 publications · 841 citations

    14

    h-index

1–5 of 2.9K

Venues

  1. Molecular Therapy — Nucleic Acids

    27 publications · 2.3K citations

    21

    h-index

  2. Biomaterials

    16 publications · 2.2K citations

    16

    h-index

  3. Angewandte Chemie International Edition

    16 publications · 2.2K citations

    15

    h-index

  4. Nucleic Acid Therapeutics

    13 publications · 586 citations

    13

    h-index

  5. Chemical Communications

    ChemComm · 13 publications · 797 citations

    12

    h-index

1–5